Filaggrin immunostaining (red), nuclei (blue) on skin explant cutting
The barrier alteration (BA) model reproduces cutaneous barrier disruption by exposing skin explants to dehydration agents.
These agents reduce skin barrier.
In this model, filaggrin located in the granular layer is decreased by the treatment and can be restored by ingredient or final product application.